NCT04844892View on ClinicalTrials.gov

Phrenic Nerve Stimulation-Induced Lung ReAeration Trial

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 13, 2023

Conditions
Acute Respiratory Distress SyndromeVentilation Therapy; Complications
Interventions
DEVICE

Lungpacer PROTECT Diaphragm Pacing Therapy

PROTECT diaphragm pacing therapy is intended to stimulate the diaphragm to preserve and improve inspiratory muscle strength in mechanically ventilated patients.

Trial Locations (1)

75651

Hôpital La Pitié-Salpêtrière, Paris

Sponsors
All Listed Sponsors
lead

Lungpacer Medical Inc.

INDUSTRY